Evidence map›Paper›PMID 42043231›Full record

ArticleViruses2026

LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway.

Jiaqi Zhang, Hanlin Zhang, Yi Chen, Hanfei Liu, Shuhuang Peng, Jiwei Zhao, Zhe Luan, Yujian Zhang, Meng Dong, Wanzhu Jin and 1 more

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiaqi ZhangMedical School of Chinese People's Liberation Army, Beijing 100853, China.
Hanlin ZhangState Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Yi ChenMedical School of Chinese People's Liberation Army, Beijing 100853, China.ORCID 0000-0003-1187-1859
Hanfei LiuMedical School of Chinese People's Liberation Army, Beijing 100853, China.
Shuhuang PengMedical School of Chinese People's Liberation Army, Beijing 100853, China.
Jiwei ZhaoMedical School of Chinese People's Liberation Army, Beijing 100853, China.
Zhe LuanDepartment of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China.ORCID 0000-0002-0003-1195
Yujian ZhangState Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0009-0001-1010-9195
Meng DongState Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0002-8523-8602
Wanzhu JinState Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Gang SunMedical School of Chinese People's Liberation Army, Beijing 100853, China.

Funding

China Postdoctoral Science Foundation 2023T160641National Key Research and Development Program of China 2023YFF1305404National Natural Science Foundation of China 32170898
6 · The paper itself

Abstract

LL-37, a 37-amino acid human-derived antimicrobial peptide, was shown in our earlier clinical study to shorten the negative conversion time of the Omicron BA.5.1.3 variant of SARS-CoV-2. In this work, we investigated the broad mechanism of LL-37 by examining its inhibitory effect on non-enveloped virus

Indexed as

Antimicrobial Cationic PeptidesAntiviral AgentsEnterovirus A, HumanEnterovirus InfectionsMAP Kinase Signaling SystemAnimalsCathelicidinsCell LineErbB ReceptorsHumansSignal TransductionUp-RegulationVirus ReplicationAntimicrobial Cationic PeptidesAntiviral AgentsCathelicidinsEGFR protein, humanErbB ReceptorscathelicidinEV71host defense peptideSTAC

Identifiers

PMID42043231
PMCPMC13120454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.